AiCME - Aiming to Minimize the Risk of Recurrence in Early Breast Cancer: Integrating Risk Assessment and Adjuvant Therapies into Practice (ID 37)

Tools to Guide Risk Assessment and Adjuvant Treatment Decisions in HR-positive, HER2-negative Early Breast Cancer: A Focus on Best Practices (ID 437)

Lecture Time
12:30 - 12:30
Speakers
  • All Speakers (na, Swaziland)
Authors
  • All Speakers (na, Swaziland)
Room
Hamburg Hall
Date
Thu, 05.05.2022
Time
12:30 - 13:30